Literature DB >> 6088731

Complications following chemonucleolysis with collagenase.

J Artigas, M Brock, H M Mayer.   

Abstract

Lumbar disc tissue from eight patients previously submitted to unsuccessful chemonucleolysis with collagenase was studied by light and scanning electron microscopy (SEM). Similar material from eight patients subjected to primary disc surgery served as control. The control discs revealed the characteristic signs of degeneration of collagen tissue, microcystic areas, and giant chondromas. However, the anulus fibrosus and the end-plates remained intact. Following chemonucleolysis with collagenase, "digestion" of the nucleus pulposus, the anulus fibrosus, and extensive damage to the end-plates, bone, ligaments, and epidural fat were seen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088731     DOI: 10.3171/jns.1984.61.4.0679

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Evaluation of digestive proteinases from the Antarctic krill Euphasia superba as potential chemonucleolytic agents. In vitro and in vivo studies.

Authors:  J Melrose; A Hall; C Macpherson; C R Bellenger; P Ghosh
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

2.  Chemonucleolysis with Chondroitin Sulfate ABC Endolyase for Treating Lumbar Disc Herniation: Exploration of Prognostic Factors for Good or Poor Clinical Outcomes.

Authors:  Katsuhiko Ishibashi; Muneyoshi Fujita; Yuichi Takano; Hiroki Iwai; Hirohiko Inanami; Hisashi Koga
Journal:  Medicina (Kaunas)       Date:  2020-11-19       Impact factor: 2.430

3.  Low-Dose Collagenase Chemonucleolysis Combined with Radiofrequency in the Treatment of Lumbar Disc Herniation: A 10-Year Retrospective Study.

Authors:  Meng Wang; Xuexue Zhang; Yaoping Yu; Gang Xu; Jinping Nie; Bo Yu; Xuezhong Cao; Mizhen Qiu; Yunhua Liao; Daying Zhang; Yi Yan
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-23       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.